ClinicalTrials.Veeva

Menu

Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria

L

Ludwig Boltzmann Institute for Lung Health

Status

Enrolling

Conditions

Interstitial Lung Disease

Study type

Observational

Funder types

Other

Identifiers

NCT06522334
ILD Registry

Details and patient eligibility

About

The goal of this registry is to systematically record epidemiological and clinical data throughout the whole interstitial lung disease course - starting with the diagnosis, therapy, follow up of lung function, symptom control, adverse events, medication, survival and death.

There are no additional interventions regarding this registry.

Enrollment

400 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosis of interstitial lung disease
  • written informed consent

Exclusion criteria

  • to not comprehend and rightfully judge participation

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems